This inventor holds 14 USPTO granted patents and 3 published patent applications, plus 5 CIPO patents and 4 EPO patents. Top assignee: Novagen Holding Corporation. Active years: 2009-2022.
Company Filing History:
Years Active: 2009-2022
Title: Innovations of Inventor Yong Du
Introduction
Yong Du is a prominent inventor based in Vancouver, Canada, known for his significant contributions to the field of biotechnology. With a total of 14 patents to his name, he has made remarkable advancements in the development of fusion proteins that enhance therapeutic efficacy.
Latest Patents
One of Yong Du's latest patents is focused on recombinant human EPO-FC fusion proteins with a prolonged half-life and enhanced erythropoietic activity in vivo. This invention describes a recombinant fusion protein that comprises a human erythropoietin peptide portion linked to an immunoglobulin peptide portion. The fusion protein boasts a half-life in vivo that is at least three times higher than that of naturally occurring or recombinant native human erythropoietin. Additionally, it exhibits enhanced erythropoietic bioactivity compared to native human erythropoietin. The invention also includes nucleic acid and amino acid sequences encoding the fusion protein, as well as methods for producing it. Another notable patent involves fusion proteins with mutated immunoglobulin hinge regions, designed to prevent the formation of disulfide bonds, thereby improving their therapeutic potential.
Career Highlights
Yong Du has established himself as a key figure in the biotechnology sector, particularly through his work at Novagen Holding Corporation. His innovative research has led to breakthroughs that have the potential to significantly impact medical treatments and patient care.
Collaborations
Yong Du has collaborated with notable colleagues, including Haitao Wang and Rui Zhang, to further advance his research and development efforts in the field of biotechnology.
Conclusion
Yong Du's contributions to the field of biotechnology through his innovative patents and collaborative efforts highlight his role as a leading inventor. His work continues to pave the way for advancements in therapeutic applications and improved patient outcomes.